🚀 Sam Altman is diving into the trendy world of neurointerfaces with his new venture, Merge Labs

🚀 Sam Altman is diving into the trendy world of neurointerfaces with his new venture, Merge Labs. Think of it as a potential competitor to Musk's Neuralink—but with a key twist: no invasive brain surgery or pesky electrodes involved! 🎉

Instead, the plan is to explore gene editing techniques that boost brain cells' sensitivity to ultrasound and magnetic fields. 🧬 Sure, saying it's "easier to introduce genes into cells" than sticking electrodes in your noggin may sound a bit sketchy, but that’s the bold path they’re treading.

Altman dreams of a future where you can think something and get a response from ChatGPT—without any brain bling! 🤖💭 He’s already roped in Mikhail Shapiro, a molecular biology whiz known for his work on gene therapy at Caltech.

If they pull this off, a non-invasive interface could totally revolutionize how we interact with digital products. Stay tuned! 🔍✨ #TechTrends #Neurotech